Tekla Life Sciences Investors Live Stock Price Today, Share Analysis and Chart

Name: Tekla Life Sciences Investors: Is Infosys Ltd. worth buying?
Item: Tekla Life Sciences Investors
Rating: 1.83241675
Author: Trendlyne DVM scores

about

abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in secur...

14.13 -0.12 (-0.84%)

33.93% Gain from 52W Low

99,647

XNYS Volume

XNYS 10 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

9.7 / 100

Technically Moderately Bullish

63.6 / 100

No estimates available

Tekla Life Sciences Investors Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Tekla Life Sciences Investors Live Stock Price Today, Share Analysis and Chart

abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in secur...

33.93% Gain from 52W Low

SWOT Analysis

Tekla Life Sciences Investors Live Price Chart